feed,title,long_url,short_url
Barron's,"Don't Count Out Covid-19 Monoclonal Antibody Treatments, Analyst Says. Here Are the Stocks to Watch.",https://www.barrons.com/articles/regeneron-vir-stock-covid-19-antibody-51634310122?mod=RTA,https://j.mp/3BMYvvV
